Cyclic GMP-AMP synthase (cGAS) senses double-strand (ds) DNA in the cytosol and then catalyzes synthesis of the second messenger cGAMP, which activates the adaptor MITA/STING to initiate innate antiviral response. How cGAS activity is regulated remains enigmatic. Here, we identify ZCCHC3, a CCHC-type zinc-finger protein, as a positive regulator of cytosolic dsDNA- and DNA virus-triggered signaling. We show that ZCCHC3-deficiency inhibits dsDNA- and DNA virus-triggered induction of downstream effector genes, and that ZCCHC3-deficient mice are more susceptible to lethal herpes simplex virus type 1 or vaccinia virus infection. ZCCHC3 directly binds to dsDNA, enhances the binding of cGAS to dsDNA, and is important for cGAS activation following viral infection. Our results suggest that ZCCHC3 is a co-sensor for recognition of dsDNA by cGAS, which is important for efficient innate immune response to cytosolic dsDNA and DNA virus.
The innate immune system is the first line of host defense against microbial infection. Upon microbial infection, cellular pattern recognition receptors (PRRs) recognize structurally conserved microbial components called pathogen-associated molecular patterns (PAMPs), which triggers a series of signaling events that lead to the induction of type I interferons (IFNs), pro-inflammatory cytokines and other downstream effectors. These downstream effectors mediate the inhibition of microbial replication, clearance of infected cells and facilitation of adaptive immune response to eliminate infected pathogens1,2,3,4,5.
Microbial nucleic acids are major PAMPs that are sensed by cellular PRRs after microbial infection. Among identified PRRs, endosomal Toll-like receptor 3 (TLR3) and retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), including RIG-I and MDA5, play important roles in recognition of viral RNA1. Previously, it has been shown that several DNA sensors including Sox26, TLR97, AIM28, DAI9, RNA polymerase III10,11, IFI1612, DDX4113, and LSm14A14 can detect cytosolic or microbial DNA in distinct cells or mouse models. However, these proteins are not universally required for cytosolic DNA sensing in distinct cell types or in vivo5. A nucleotidyltransferase family member, called cyclic GMP-AMP (cGAMP) synthase (cGAS), has been defined as a key DNA sensor in various cell types and mice15. It has been demonstrated that cGAS recognizes cytosolic DNAs derived from various types of virus, including DNA viruses (such as herpes virus, adenovirus, and hepatitis B virus) and retroviruses (such as HIV-1)16,17,18,19. cGAS also detects other pathogenic DNA and mitochondrial DNA in the cytosol20,21,22. Genetic studies have demonstrated that cGAS plays crucial roles in innate immune responses to cytosolic DNA and various DNA viruses23.
After recognition of dis-located cellular or microbial DNA in the cytosol, cGAS undergoes oligomerization and catalyzes the synthesis of the second messenger molecule cGAMP from ATP and GTP24,25, which in turn binds to and activates the adaptor MITA (also known as STING, MPYS, and ERIS) located in the endoplasmic reticulum (ER)26,27,28,29,30. MITA then translocates from the ER via ER-Golgi intermediate compartments and Golgi apparatus to perinuclear punctuate structures. During the trafficking processes, MITA recruits the kinaseTBK1 and the transcription factor IRF3, leading to their phosphorylation and activation as well as induction of downstream effector genes31,32.
Structural studies have revealed certain modes on how cGAS recognizes DNA. cGAS contains an N-terminal domain (aa1-160) with an unknown function and a C-terminal Mab21 domain (aa161-522) that belongs to the nucleotidyltransferase (NTase) superfamily. The N-terminal part of the Mab21 domain is a NTase fold (aa148-370) that is important for sensing of DNA and synthesis of cGAMP15,33. Upon DNA binding, cGAS forms a 2:2 dimer (composed of two cGAS and two DNA molecules) or higher-order complexes, leading to the activation of cGAS34,35. Recent studies have also demonstrated that longer DNA ligands activate cGAS at a higher rate than shorter DNA, and the formation of stable cGAS2n-DNA2 ladders (n ≧ 2) is important for activation of cGAS36. However, it has been shown that the affinity of cGAS for DNA is low and cGAS can recognize DNA with distinct properties33,35,37, which are in contrast with its ability to specifically respond to small quantities of microbial and self DNA in the cytosol. Recently, it has been shown that the cellular protein PQBP1 serves as a co-sensor by directly binding to single-strand (ss) reverse-transcribed HIV-1 DNA and interacting with cGAS to initiate innate immune response. However, PQBP1 is not required for cGAS-dependent responses to all cytosolic double-strand (ds) DNA but only the ssDNA derived from retroviral infection38. Whether cGAS requires co-sensors analogous to PQBP1 to detect non-retroviral cytoplasmic dsDNA is still an unanswered question in the field. In this study, we identified the CCHC-type zinc-finger (ZF) protein ZCCHC3 as a co-sensor of cGAS in innate immune response to cytosolic dsDNA and DNA virus. Deficiency of ZCCHC3 impaired cytosolic dsDNA- or DNA virus-triggered induction of type I IFNs, pro-inflammatory cytokines and other effectors in cells and mice. Zcchc3−/− mice were more susceptible to lethal infection by DNA viruses. Mechanistically, ZCCHC3 bound to dsDNA, promoted the binding of cGAS to dsDNA, and was important for the enzymatic activity of cGAS following dsDNA stimulation or DNA virus infection. Our findings suggest that ZCCHC3 acts as a co-sensor of cGAS for recognition of dsDNA and plays an essential role in innate immune response to DNA virus.
ZCCHC3 positively regulates dsDNA-triggered signaling
To identify candidate molecules involved in innate immune response, we screened ~10,000 independent human cDNA clones for their abilities to regulate IFN-stimulated response element (ISRE) activation by reporter assays and identified ZCCHC3 as a candidate protein. Reporter assays indicated that overexpression of ZCCHC3 activated the IFN-β promoter (which is driven by ISRE and κB enhancers) by itself and potentiated herpes simplex virus 1 (HSV-1)-induced activation of the IFN-β promoter in a dose-dependent manner in HEK293 cells (Fig. 1a). qPCR experiments indicated that overexpression of ZCCHC3 potentiated HSV-1-induced transcription of IFNB1, ISG56 and CXCL10 genes in primary human foreskin fibroblasts (HFFs) (Fig. 1b). Previously, it has been shown that transfected dsDNAs, such as the 120-mer dsDNA representing the genome of HSV-1 (HSV120), dsDNA of ~90 bp (dsDNA90), 70-mer dsDNA representing vaccinia virus (VACV) genome (VACV70), and 45-mer IFN stimulatory DNA (ISD45) can efficiently induce transcription of downstream effector genes28,39. As shown in Fig. 1c, overexpression of ZCCHC3 potentiated transcription of IFNB1, ISG56 and CXCL10 genes induced by transfected HSV120 in HFFs. These results suggest that ZCCHC3 is involved in cytosolic dsDNA- and DNA virus-triggered induction of downstream antiviral genes.
To determine whether endogenous ZCCHC3 is important for dsDNA-triggered signaling, we generated ZCCHC3-deficient HFFs and THP1 cells by the CRISPR-Cas9 method. qPCR analysis indicated that knockout of ZCCHC3 dramatically inhibited HSV-1- and transfected dsDNA-induced transcription of downstream genes such as IFNB1, ISG56, CXCL10, and IL6 in HFFs (Fig. 1d, e). In addition, the phosphorylation of TBK1 and IRF3 induced by HSV-1 in ZCCHC3-deficient HFFs was markedly inhibited compared with control cells (Fig. 1f). Similarly, the transcription of downstream genes and phosphorylation of TBK1and IRF3 induced by HSV-1 in ZCCHC3-deficient THP1 cells was markedly inhibited compared with control cells (Supplementary Fig. 1). In contrast, IFN-β-induced transcription of ISG56 and RIG-I and the phosphorylation of STAT1(Y701) was comparable between ZCCHC3-deficient and control THP1 cells (Fig. 1g, h). These results suggest that ZCCHC3 is an important component in cytosolic dsDNA- and DNA virus-triggered induction of downstream effector genes.
ZCCHC3 is essential for innate immune response to DNA virus in mice
To further investigate the roles of ZCCHC3 in vivo, we generated Zcchc3 knockout mice. qPCR analysis indicated that transcription of downstream genes including Ifnb1, Cxcl10, and Il6 following infection with HSV-1 and VACV was markedly inhibited in Zcchc3−/− mouse bone marrow-derived macrophages (BMDMs) (Fig. 2a) and dendrite cells (BMDCs) (Supplementary Fig. 2A). Consistently, ZCCHC3-deficiency dramatically inhibited murine cytomegalovirus (MCMV)-, VACV-, or HSV-1-induced transcription of downstream genes in mouse lung fibroblasts (MLFs) and embryonic fibroblasts (MEFs) (Fig. 2b, c). In addition, transcription of downstream genes such as Ifnb1, Cxcl10, and Il6 following transfection of the synthetic dsDNA, ISD45, HSV120, and VACV70, was inhibited in BMDCs (Supplementary Fig. 2B), MLFs and MEFs (Fig. 2d), suggesting that ZCCHC3 has a general role in dsDNA-triggered signaling in distinct cell types. We further investigated the transcription of Ifnb1 gene induced by transfection of increased amounts of HSV120 in Zcchc3−/− and Zcchc3+/+ MLFs. The results indicated that HSV120-induced transcription of Ifnb1 gene was inhibited better in Zcchc3−/− compared with Zcchc3+/+ MLFs when lower doses of DNA were transfected (Fig. 2e), suggesting that ZCCHC3 plays a more important modulatory role on cGAS activation when cytosolic dsDNA concentration is low.
Further experiments indicated that the secretion of IFN-β and IL-6 were markedly decreased in Zcchc3−/− BMDCs following HSV-1 infection (Supplementary Fig. 2C) or transfection of ISD45 and HSV120 (Supplementary Fig. 2D). Consistently, phosphorylation of TBK1, IRF3, and IκBα induced by HSV-1 was inhibited in Zcchc3−/− in comparison to wild-type BMDMs (Fig. 2f) and BMDCs (Supplementary Fig. 2E). In contrast, transcription of Isg56 and Rig-I genes triggered by IFN-β was comparable between Zcchc3−/− and Zcchc3+/+ MLFs (Supplementary Fig. 2F). Collectively, these data suggest that ZCCHC3 modulates cytosolic dsDNA- and DNA virus-triggered induction of downstream antiviral genes in primary mouse immune cells and fibroblasts.
We next determined the importance of ZCCHC3 in host defense against viral infection in vivo. We found that induction of serum cytokines including IFN-β, CXCL10, and IL-6 following infection of the DNA viruses HSV-1, VACV, and MCMV was severely impaired in Zcchc3−/− in comparison to Zcchc3+/+ mice (Fig. 3a). Given that HSV-1 is a neurotropic virus and the leading cause of sporadic viral encephalitis, we intra-nasally infected Zcchc3+/+ and Zcchc3−/− mice with HSV-1 and examined HSV-1 genomic copy numbers and viral titers in the brains. The results indicated that the amounts of HSV-1 genomic copy numbers and viral titers in the brains were much higher in Zcchc3−/− than Zcchc3+/+ mice at 6 days after viral infection (Fig. 3b). In addition, we found that Zcchc3−/− mice were more susceptible to HSV-1-or VACV- induced death (Fig. 3c). Consistently, the lungs of Zcchc3−/− mice showed greater infiltration of immune cells and tissue damage compared to that of Zcchc3+/+mice after HSV-1 infection (Fig. 3d). These results indicated that ZCCHC3 is essential for host defense against DNA virus in vivo.
ZCCHC3 interacts with cGAS
We next investigated the mechanisms on how ZCCHC3 is involved in cytosolic dsDNA-triggered signaling. Quantitative mass spectrometry showed that the levels of cGAMP induced by transfection of HSV120 was markedly reduced in Zcchc3−/− in comparison to Zcchc3+/+ MLFs (Fig. 4a), suggesting that ZCCHC3 is essential for dsDNA-induced catalytic activity of cGAS. In contrast, ZCCHC3-deficiency had no effects on cGAMP-induced transcription of downstream genes such as Ifnb1, Cxcl10, and Il6 (Fig. 4b). These results suggest that ZCCHC3 acts upstream of cGAMP.
We next determined whether ZCCHC3 is associated with signaling components in dsDNA-triggered signaling pathways. Co-immunoprecipitation experiments indicated that ZCCHC3 was associated with cGAS but not MITA, TBK1, or IRF3 in mammalian overexpression system (Fig. 4c). Confocal microscopy indicated that ZCCHC3 was co-localized with cGAS in the cytoplasm (Fig. 4d). Furthermore, proximity ligation assay (PLA) showed that the co-localization of ZCCHC3 and cGAS in the cytoplasm was increased after HSV-1 infection or HSV120 transfection in MEFs (Fig. 4e). Consistently, endogenous co-immunoprecipitation experiments indicated that ZCCHC3 was barely associated with cGAS in un-infected cells and their association was increased after HSV-1 infection or HSV120 transfection (Fig. 4f).
To further study which domains of ZCCHC3 and cGAS are involved in their interaction, we constructed a series of truncation mutants of ZCCHC3 and cGAS. Domain mapping experiments indicated that the NTase fold (aa213-382) and the C-terminal fragment (aa383-522) of cGAS could independently interact with ZCCHC3 (Supplementary Fig. 3A). On the other hand, the C-terminal ZF domains (aa300-404) of ZCCHC3 interacted very weakly while its N-terminus failed to interact with cGAS, suggesting that the full-length protein of ZCCHC3 is important for its efficient interaction with cGAS (Supplementary Fig. 3B). Taken together, these results suggest that ZCCHC3 targets cGAS after viral infection.
ZCCHC3 acts as a co-sensor of cGAS for recognition of dsDNA
Since ZCCHC3 is a CCHC-type ZF protein which has been expected to bind to nucleic acids, we next examined whether ZCCHC3 binds to dsDNA. As shown in Fig. 5a, ZCCHC3 could bind to dsDNA such as poly(dA:dT) (B-DNA), poly(dG:dC) (Z-DNA) and HSV120 but not ssDNA in pull-down assays. In these experiments, the RNA sensor MDA5 did not bind to dsDNA. Deletion analysis indicated that the three ZFs could independently bind to HSV120 (Fig. 5b).
We further examined whether ZCCHC3 binds to viral DNA in infected cells by “foot-print” experiments. Following HSV-1 infection, we immunoprecipitated cGAS, ZCCHC3, and RIG-I, and the protein-bound viral DNA was detected by qPCR with primers targeting various regions of HSV-1 DNA. The results indicated that cGAS and ZCCHC3 but not RIG-I could bind to HSV-1 DNA, and in most cases to overlapping regions of the HSV-1 genome (Fig. 5c).
We further investigated whether and how ZCCHC3 modulates cGAS activity. In vitro pull-down analysis indicated that overexpression of ZCCHC3 enhanced the binding of cGAS to HSV120 (Fig. 6a), whereas ZCCHC3-deficiency inhibited the binding of cGAS to HSV120 in HEK293 cells (Fig. 6b). Consistently, ZCCHC3-deficiency inhibited the binding of endogenous cGAS to HSV120 in primary MLFs and MEFs (Fig. 6c). We have further produced recombinant ZCCHC3 and cGAS, and then examined the binding affinities of these proteins to dsDNA by Microscale thermophoresis technology (MST). The results indicated that ZCCHC3 and cGAS could bind to the synthetic dsDNA HSV60 with an affinity of Kd = 866±48 or 600±26.8 nM respectively. In addition, recombinant ZCCHC3 bound to cGAS with a higher affinity (Kd = 79.6±12.5 nM). The complex of ZCCHC3 and cGAS could bind to HSV60 with a dramatic higher affinity (Kd = 7.62±0.595 nM) than each of them alone (Fig. 6d). Collectively, these results suggest that ZCCHC3 promotes recognition of dsDNA by cGAS.
We further investigated whether ZCCHC3 promotes sensing of dsDNA by cGAS is dependent on its DNA binding capacity. As shown in Fig. 6e, reconstitution of ZCCHC3 but not its mutant lacking the ZF domains rescued HSV-1-induced transcription of Ifnb1, Cxcl10, and Il6 genes in Zcchc3−/− MLFs, suggesting that the DNA binding capacity of ZCCHC3 is important for its role in modulating cGAS activation.
Since ZCCHC3-deficiency causes marked but not complete inhibition of dsDNA-induced signaling, whereas cGAS-deficiency has a more dramatic effect, we determined whether the effects of ZCCHC3 on dsDNA-induced signaling are mediated by cGAS. qPCR analysis indicated that overexpression of ZCCHC3 potentiated transcription of Ifnb1, Isg56, and Cxcl10 genes following HSV120 transfection in wild-type L929 cells. However, cGAS-deficiency dramatically inhibited HSV120-induced and ZCCHC3-mediated transcription of the downstream genes (Fig. 6f), suggesting that the effects of ZCCHC3 on dsDNA-induced transcription of downstream genes are mediated by cGAS.
We further investigated whether the expression of endogenous ZCCHC3 and cGAS in various cells and tissues is correlated. We found that ZCCHC3 was ubiquitously expressed in different human cell lines including THP1, HFF, HCT116, A549, HepG2, and HeLa cells, as well as primary human immune cells including macrophages and DCs (Supplementary Fig. 4A). The expression levels of ZCCHC3 were correlated to those of cGAS in all the examined human cell lines or primary immune cells except HCT116 (Supplementary Fig. 4A). We also found that the mRNAs of both Zcchc3 and cGas were expressed widely in most mouse tissues (Supplementary Fig. 4B). Transcription of cGas but not Zcchc3 was induced by viral infection or IFN-β stimulation in murine lung fibroblasts (MLFs) (Supplementary Fig. 4C).
ZCCHC3 modulates cGAS oligomerization
Previously, it has been shown that cGAS oligomerization is important for its activation after binding to dsDNA34. Co-immunoprecipitation experiments indicated that ZCCHC3 enhanced self-association of cGAS, which was further enhanced following stimulation with transfected HSV120 (Fig. 7a). Conversely, ZCCHC3-deficiency markedly inhibited the self-association of cGAS in HEK293 cells (Fig. 7b). In addition, oligomerization of cGAS induced by transfected VACV70 was decreased in Zcchc3−/− in comparison to Zcchc3+/+ MLFs (Fig. 7c).
In our earlier experiments (Fig. 4a), we have shown that ZCCHC3-deficiency dramatically inhibited cytosolic dsDNA-triggered synthesis of cGAMP (Fig. 4a). Collectively, these results suggest that ZCCHC3 is important for cytosolic dsDNA-induced oligomerization and enzymatic activity of cGAS.
It has been well established that cGAS is a ubiquitous sensor for cytosolic dsDNA, which plays an essential role in innate immune response to microbial and dis-located self DNA15,23. Since cGAS recognizes dsDNA with low specificity, it is unknown how cGAS acts as an efficient and specific sensor for cytosolic dsDNA. In this study, we identified the CCHC-type ZF protein ZCCHC3 as a co-sensor for cGAS, which is required for efficient innate immune response to cytosolic and viral dsDNA.
Several lines of evidence suggest that ZCCHC3 plays an important role in innate immune response to cytosolic dsDNA and DNA virus. Overexpression of ZCCHC3 potentiated HSV-1- or cytosolic dsDNA-induced transcription of downstream effector genes, whereas knockout of ZCCHC3 had the opposite effects in various cell types. Reconstitution of ZCCHC3 rescued HSV-1-triggered induction of downstream cytokines in Zcchc3−/− cells. The serum cytokines such as IFN-β, CXCL10, and IL-6 induced by infection of HSV-1, VACV, and MCMV were impaired in Zcchc3−/− in comparison to Zcchc3+/+ mice, and ZCCHC3-deficiency renders the mice more susceptible to HSV-1- or VACV-induced death. The amounts of HSV-1 genomic copy numbers and viral titers were markedly increased in the brains of Zcchc3−/− mice in comparison to their wild-type counterparts after HSV-1 infection. In addition to a role in innate immune response to DNA virus, we also found that ZCCHC3 plays an important role in innate immune response to RNA virus, which will be characterized and reported in a separate study.
Mechanistic studies suggest that ZCCHC3 acts as a general co-sensor for recognition of dsDNA by cGAS. Firstly, ZCCHC3-deficiency inhibited HSV-1-triggered induction of cGAMP but not cGAMP-induced transcription of downstream effector genes. In addition, ZCCHC3-mediated induction of downstream genes was abolished in cGas−/− cells. Cellular and biochemical experiments indicated that ZCCHC3 interacted with cGAS, and their endogenous association was induced by HSV-1 infection or dsDNA stimulation. These results suggest that ZCCHC3 functions through cGAS. Second, in vitro pull-down analysis showed that ZCCHC3 itself bound to dsDNA through its ZF domains. cGAS also contains a CCHC-type ZF motif that is required for its binding to dsDNA15,33,40. Foot-print experiments indicated that ZCCHC3 and cGAS bound to overlapping regions of naturally infected HSV-1 DNA. In mammalian cells, overexpression of ZCCHC3 promoted the binding of cGAS to dsDNA, whereas ZCCHC3-deficiency had opposite effects. Third, MST experiments with purified recombinant proteins indicated that ZCCHC3 and cGAS could bind to synthetic dsDNA with similar affinity. ZCCHC3 and cGAS could also bind to each other with a higher affinity than their respective affinities to dsDNA. The complex of ZCCHC3 and cGAS could bind to dsDNA with a dramatic higher affinity than each of them alone. Collectively, these results suggest that ZCCHC3 acts as a co-sensor of cGAS to promote its binding to dsDNA and subsequent enzymatic activation.
Based on our results, we conclude that viral infection induces the association of ZCCHC3 and cGAS, which have a high affinity to viral dsDNA, leading to cGAS activation and induction of downstream effector genes. Currently, we do not know whether individual binding of ZCCHC3 or cGAS to dsDNA promotes the interaction of the two proteins, and subsequently increases the affinity of the complex to dsDNA, or alternatively, viral infection firstly induces formation of ZCCHC3 and cGAS complex through unknown mechanisms, which has much higher affinity to dsDNA than each of them alone. It has been shown that the cellular protein PQBP1 serves as a co-sensor for recognition of reverse-transcribed HIV-1 ssDNA by cGAS, but is not required for cGAS-dependent responses to cytosolic dsDNAs38. In light of this observation, ZCCHC3 may act as a general co-sensor of cGAS for recognition of cytosolic dsDNA originated from dis-located self or microbial DNA, and the identification of ZCCHC3 represents an important step towards our understanding of innate immune response to dis-located self DNA or DNA pathogens.
Zcchc3−/− mice on the C57BL/6 background were generated by the CRISPR/Cas9 method and obtained from the Wuhan University A3 Animal Center. The mice were bred in specific pathogen-free facilities at Wuhan University College of Life Sciences. The animal care and use protocol was adhered to the Chinese National Laboratory Animal-Guideline for Ethical Review of Animal Welfare. The protocols and procedures for mice experiments in this study were approved by the Wuhan University College of Life Sciences Animal Care and Use Committee (approval number WDSKY0200902-2). Six to eight week-old mice were used in the experiments and littermates were used as controls. Experiments were conducted without blinding, with age- and sex-matched mice.
Reagents, antibodies, cells, and viruses
Poly(dA:dT), 2′ 3′-cGAMP, and Lipofectamine 2000 (InvivoGen); polybrene (Millipore); SYBR (Bio-Rad); FuGene and Dual-Specific Luciferase Assay Kit (Promega); digitonin (Sigma); puromycin and EZ-link Psoralen-PEG3-Biotin (Thermo); streptavidin agarose (Solulink); ELISA kits for murine IFN-β (PBL), IL-6 (BioLegend), and CXCL10 (BOSTER); recombinant IFN-β (R&D systems) were purchased for the indicated manufacturers.
Mouse monoclonal antibodies against HA (BioLegend, 901515; 1:2000), FLAG (Sigma, F3165; 1:2000) and β-actin (Sigma, A2228; 1:3000) and phosphor-IκBα (Cell Signaling Technology, 9246 S; 1:1000); rabbit monoclonal antibodies against cGAS (Cell Signaling Technology, 66546 S/31659 S; 1:1000), phosphor-Tyrosine701-STAT1 (Cell Signaling Technology, 9167 S; 1:1000) and phosphor-IRF3 (Cell Signaling Technology, 4947 S; 1:1000), phosphor-TBK1 (Abcam, ab109272; 1:1000) and TBK1(Abcam, ab40676; 1:2000), IRF3 (Santa Cruz Biotechnology, sc-33641; 1:1000) and STAT1 (Santa Cruz Biotechnology, sc-417; 1:1000) were purchased from the indicated manufacturers. Antisera against ZCCHC3 were generated by immunizing rabbits or mice with purified recombinant ZCCHC3(133-404) (1:1000).
HEK293 cells (Cat # CRL-11268) and THP1 cells (Cat # TIB-202) were obtained from ATCC. HFFs were provided by Dr. Min-Hua Luo (Wuhan Institute of Virology, CAS). HSV-1 (KOS strain), VACV (Tian-Tan Strain) and MCMV were purchased from China Center for Type Culture Collection.
Expression plasmids for HA-, FLAG-, or GFP-tagged ZCCHC3 and its truncation mutants, and HA-, FLAG-, or RFP-tagged cGAS and its truncation mutants were constructed by standard molecular biology techniques. Expression plasmids for HA-tagged MDA5, MITA, TBK1, and IRF3, and the IFN-β promoter reporter plasmids were previously described30,41,42,43,44.
Preparations of primary mouse cells
For preparation of BMDMs, mouse bone marrow-derived monocytes (5 × 106) were cultured in 100-mm dishes in 5 ml 10% M-CSF-containing conditional medium from L929 cells for 3–5 days. For preparation of BMDCs, mouse bone marrow-derived monocytes (5 × 106) were cultured in medium containing murine GM-CSF (50 ng/ml) for 6–8 days. For preparation of lung fibroblasts, lungs were minced and digested in calcium and magnesium free HBSS containing 10 μg/ml type II collagenase and 20 μg/ml DNase I for 1 h at 37 °C with shaking. Cell suspension was centrifuged at 448 × g for 5 min. The cells were then plated in culture medium (1:1 [v/v] DMEM/Ham’s F-12 containing 10% FBS, 50 U/ml penicillin, 50 μg/ml streptomycin, 15 mM HEPES, 2 mM l-glutamine). MEFs were prepared from day 12.5 embryos and cultured in DMEM supplemented with 10% FBS.
The following oligonucleotides were used to stimulate cells:
Transfection and reporter assays
HEK293 cells were transfected by standard calcium phosphate precipitation method. HeLa cells were transfected by FuGENE. HFFs, MLFs, and MEFs were transfected by Lipofectamine 2000. To ensure that each transfection receives the same amount of total DNA, the empty control plasmid was added to each transfection. To normalize for transfection efficiency, pRL-TK (Renilla luciferase) reporter plasmid (0.01 μg) was added to each transfection. Luciferase assays were performed using a Dual-Specific Luciferase Assay Kit. Firefly luciferase activities were normalized on the basis of Renilla luciferase activities.
Total RNA was isolated for qPCR analysis to measure mRNA abundance of the indicated genes. Data shown are the relative abundance of the indicated mRNA derived from human or mouse cells normalized to that of GAPDH. Gene-specific primer sequences were listed in Supplementary Table 1.
Genome engineering was performed using the CRISPR-Cas9 system45,46. Double-stranded oligonucleotides corresponding to the target sequences were cloned into the lenti-CRISPR-V2 vector and cotransfected with packaging plasmids into HEK293 cells. Two days after transfection, the viruses were harvested and used to infect HFFs or THP1 cells. The infected cells were selected with puromycin (1 μg/ml) for at least 5 days. The following sequences were targeted for human ZCCHC3 cDNA. #1: 5′-AGGGCGAATTCCGCGAGCCG-3′; and #2: 5′-CGGCCGCGAGAAGATGGGCT-3′.
Viral plaque assays
Eight-week-old mice were infected with HSV-1 for 6–7 days, the brains of mice were weighed and homogenized for 5 s in PBS. After homogenization, the brain suspensions were centrifuged at 1620 × g for 30 min, and the supernatants were used for plaque assays. Vero cells were seeded in 24-well plates, and the cells were infected by incubation for 2 h at 37 °C with serial dilutions of the brain suspensions. After infection for 2 h, 2% methylcellulose was overlaid, and the plates were incubated for 36–48 h. The overlay was removed, and cells were fixed with 4% paraformaldehyde for 20 min and stained with 1% crystal violet for 20 min before plaque counting.
BMDCs were stimulated with viruses or transfected with synthetic nucleic acids for 18 h. The culture media were collected for measurement of IFN-β and IL-6. Eight-week-old Zcchc3+/+ and Zcchc3−/− mice were intra-nasally infected with HSV-1, VACV, and MCMV for 6 h, and then the sera of mice were collected for measurement of IFN-β, CXCL10, and IL-6 by ELISA.
Co-immunoprecipitation and immunoblotting analysis
Cells were lysed in NP-40 lysis buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride). For each immunoprecipitation, a 0.4-mL aliquot of the lysate was incubated with the indicated antibody or control IgG (0.5 μg, or 0.5 μl for antiserum) and 25 μL of a 1:1 slurry of Protein G Sepharose (GE Healthcare) for 2 h. Sepharose beads were washed three times with 1 mL of lysis buffer containing 0.5 M NaCl. The precipitates were analyzed by standard immunoblot procedures. Uncropped scans of the immunoblots are provided in Supplementary Figs. 5–12.
In vitro pull-down assays
HEK293 cells transfected with the indicated plasmids were lysed in NP-40 lysis buffer. Lysates were incubated with biotinylated-HSV120 for 1 h at 4 °C, and then incubated with streptavidin beads for another 2 h at 4 °C. The beads were washed three times with lysis buffer and analyzed by immunoblotting with the indicated antibodies.
Fluorescent confocol microscopy
HeLa cells were transfected with the indicated plasmids by FuGENE. After transfection for 20 h, the cells were fixed with 4% paraformaldehyde for 15–20 min and then washed with PBS for 3 times. The nuclei were stained with DAPI for 2 min and then washed with PBS for 3 times. Imaging of the cells was carried out using Nikon A1 MP confocal microscope under a ×60 oil objective.
Proximity ligation assay (PLA)
The PLA reagents were purchased from Sigma and the experiments were performed following the manufacturer’s instructions. Briefly, MEFs were seeded on Teflon-coated glasses and cultured for 18 h. After HSV-1 infection or transfection of HSV120 for 4 h, cells were fixed with 4% paraformaldehyde for 15–20 min at room temperature followed by permealization with 0.1% TritonX-100 for 10 min. Cells were blocked in 5% BSA in PBS for 30 min and incubated in primary antibodies for 2 h. Cells were washed with wash buffer A (DUO82049) for 3 times and incubated with the secondary antibodies with PLA probes (DUO92004-30RXN, DUO92002-30RXN) for 2 h at 37 °C followed by 3 times wash with the wash buffer A. The cells were then incubated with the Ligation-Ligase solution (DUO92008) for 30 min at 37 °C followed by 3 times wash with the wash buffer A. Cells were incubated with Amplification-Polymerase solution (DUO92008) for 100 min at 37 °C followed by 3 times wash with the wash buffer B (DUO82049). The nuclei were stained with DAPI for 2 min and then washed with PBS for 3 times. Imaging of the cells was carried out using Nikon A1 MP confocal microscope under a ×60 oil objective.
Recombinant proteins purification
The cDNAs encoding for ZCCHC3 and cGAS were cloned into the pGEX-6p-1-GST plasmid. The plasmids were transformed into the BL21 E. Coli strain. Expression of the GST-fusion proteins were induced with 0.1 mM IPTG at 16 °C for 24 h. The recombinant proteins were purified with GST resins and eluted with elution buffer (PBS, 100 mM Tris-HCl pH 8.8, 40 mM reduced glutathione).
Microscale thermophoresis technology (MST)
MST analysis was performed using a NanoTemper Monolith NT.115 instrument (NanoTemper Technologies GmbH). For detecting affinity between GST-ZCCHC3 or GST-cGAS and dsDNA, 20 nM Cy5-labeled 60 bp dsDNA HSV60 (Sangon Biotech, China) was mixed with different concentrations of proteins in PBS with 100 mM Tris-HCl, pH 8.8. For detecting affinity between GST-ZCCHC3 and GST-cGAS, GST-ZCCHC3 was fluorescently labeled with a Blue-NHS labeling kit according to the manufacturer’s instructions. Lysine residues of GST-ZCCHC3 were labeled with a dye: protein molar ratio of 3. For detecting affinity between cGAS/ZCCHC3 complex and HSV60, 20 nM Cy5-labeled HSV60 was mixed with different concentrations of GST-cGAS saturated with GST-ZCCHC3 dependent on their Kd values. In these experiments, GST was used as negative control. Samples were loaded into Premium Coated Capillaries and MST measurements were performed using 20% MST power and 40% LED power at 25 °C. Laser-on and -off times were 30 and 5 s respectively. NanoTemper Analysis 1.2.20 software was used to fit the data and to determine the apparent Kd values.
Immuno-precipitation for viral DNA (Foot-print assay)
HEK293 cells were transfected with HA-tagged ZCCHC3, cGAS and RIG-I for 20 h. The cells were then infected with HSV-1 for 1 h, washed with medium and cultured for 2 more hours. Cell lysates were immunoprecipitated with IgG or anti-HA (2 μg) and protein G beads (50 μl) at 4 °C for 4 h. Before DNA extraction, a fraction of agarose beads were eluted using 2xSDS loading buffer, and boiled for 10 min by SDS-PAGE to confirm the protein precipitation. The bead-bound immunoprecipitates were washed for 3 times with lysis buffer containing 1 M NaCl. The beads were treated with elution buffer (0.1 M NaHCO3, 1% SDS) containing protease K for two times, and the supernatants were incubated for 30 min at 65 °C and subjected to phenol-chlorophorm extraction for 4 times. The aqueous phase was collected and mixed with ethanol, NaOAc and glycogen and store at −20 °C for at least 30 min. DNAs were precipitated by centrifugation for 30 min at 4 °C, washed with 75% ethanol and air-dried before resuspension in ddH2O for qPCR analysis of HSV-1 DNA. The following sequence is targeted for HSV-1 genome. nt 116395-116479: 5′-ACGACAGTGGCATAGGTTGG-3′ (forward), 5′-CCGACATCACAAGGGACCTC-3′ (reverse).
Semi-denaturing detergent agarose gel electrophoresis (SDD-AGE)
MLFs were lysed in NP-40 lysis buffer, and the cell lysates were mixed in 1x sample buffer (0.5xTBE, 10% glycerol, 2% SDS, and 0.0025% bromophenol blue) and loaded onto a vertical 2% agarose gel (Bio-Rad). After electrophoresis in the running buffer (1xTBE and 0.1% SDS) for about 2 h with a constant voltage of 100 V at 4 °C, the proteins were transferred to immobilon membrane (Millipore) for immunoblotting analysis.
Cells were mock-transfected or transfected with HSV120 (3 μg/ml) for 4 h. Cell extracts were then prepared and heated at 95 °C for 5 min to denature most proteins, which were removed by centrifugation. The supernatants containing cGAMP were delivered to MLFs pretreated with digitonin permeabilization solution (50 mM HEPES pH 7.0, 100 mM KCl, 3 mM MgCl2, 0.1 mM DTT, 85 mM Sucrose, 0.2% BSA, 1 mM ATP, 0.1 mM GTP and 10 μg/ml digitonin) at 37 °C for 30 min. Three hours later, the cells were collected for a qPCR analysis.
Unpaired Student’s t test was used for statistical analysis with GraphPad Prism Software. For the mouse survival study, Kaplan–Meier survival curves were generated and analyzed by Log-Rank test; P < 0.05 was considered significant.
The data that support the findings of this study are available from the corresponding authors upon request.
Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006).
Carpenter, S., Ricci, E. P., Mercier, B. C., Moore, M. J. & Fitzgerald, K. A. Post-transcriptional regulation of gene expression in innate immunity. Nat. Rev. Immunol. 14, 361–376 (2014).
Hiscott, J. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18, 483–490 (2007).
Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 449, 819–826 (2007).
Paludan, S. R. & Bowie, A. G. Immune sensing of DNA. Immunity 38, 870–880 (2013).
Xia, P. et al. Sox2 functions as a sequence-specific DNA sensor in neutrophils to initiate innate immunity against microbial infection. Nat. Immunol. 16, 366–375 (2015).
Lund, J., Sato, A., Akira, S., Medzhitov, R. & Iwasaki, A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198, 513–520 (2003).
Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514–518 (2009).
Takaoka, A. et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501–505 (2007).
Chiu, Y. H., Macmillan, J. B. & Chen, Z. J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138, 576–591 (2009).
Ablasser, A. et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10, 1065–1072 (2009).
Unterholzner, L. et al. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11, 997–1004 (2010).
Zhang, Z. et al. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12, 959–965 (2011).
Li, Y. et al. LSm14A is a processing body-associated sensor of viral nucleic acids that initiates cellular antiviral response in the early phase of viral infection. Proc. Natl Acad. Sci. USA 109, 11770–11775 (2012).
Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786–791 (2013).
Lahaye, X. et al. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 39, 1132–1142 (2013).
Lam, E., Stein, S. & Falck-Pedersen, E. Adenovirus detection by the cGAS/STING/TBK1 DNA sensing cascade. J. Virol. 88, 974–981 (2014).
Schoggins, J. W. et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505, 691–695 (2014).
Gao, D. et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903–906 (2013).
Collins, A. C. et al. Cyclic GMP-AMP synthase is an innate immune DNA sensor for mycobacterium tuberculosis. Cell Host Microbe 17, 820–828 (2015).
Watson, R. O. et al. The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I Interferons and activate autophagy. Cell Host Microbe 17, 811–819 (2015).
West, A. P. et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature 520, 553–557 (2015).
Li, X. D. et al. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341, 1390–1394 (2013).
Ablasser, A. et al. cGAS produces a 2’-5’-linked cyclic dinucleotide second messenger that activates STING. Nature 498, 380–384 (2013).
Diner, E. J. et al. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep. 3, 1355–1361 (2013).
Barber, G. N. STING-dependent signaling. Nat. Immunol. 12, 929–930 (2011).
Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674–678 (2008).
Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788–792 (2009).
Sun, W. et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl Acad. Sci. USA 106, 8653–8658 (2009).
Zhong, B. et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29, 538–550 (2008).
Bowie, A. The STING in the tail for cytosolic DNA-dependent activation of IRF3. Sci. Signal. 5, pe9 (2012).
Shu, H. B. & Wang, Y. Y. Adding to the STING. Immunity 41, 871–873 (2014).
Civril, F. et al. Structural mechanism of cytosolic DNA sensing by cGAS. Nature 498, 332 (2013).
Li, X. et al. Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization. Immunity 39, 1019–1031 (2013).
Zhang, X. et al. The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch-like conformational changes in the activation loop. Cell Rep. 6, 421–430 (2014).
Andreeva, L. et al. cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein-DNA ladders. Nature 549, 394–398 (2017).
Kranzusch, P. J., Lee, A. S., Berger, J. M. & Doudna, J. A. Structure of human cGAS reveals a conserved family of second-messenger enzymes in innate immunity. Cell Rep. 3, 1362–1368 (2013).
Yoh, S. M. et al. PQBP1 is a proximal sensor of the cGAS-dependent innate response to HIV-1. Cell 161, 1293–1305 (2015).
Abe, T. et al. STING recognition of cytoplasmic DNA instigates cellular defense. Mol. Cell 50, 5–15 (2013).
Kato, K., Omura, H., Ishitani, R. & Nureki, O. Cyclic GMP-AMP as an endogenous second messenger in innate immune signaling by cytosolic DNA. Annu. Rev. Biochem. 86, 541–566 (2017).
Fu, Y. Z. et al. Human cytomegalovirus tegument protein UL82 inhibits STING-mediated signaling to evade antiviral immunity. Cell Host Microbe 21, 231–243 (2017).
Luo, W. W. et al. iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING. Nat. Immunol. 17, 1057–1066 (2016).
Wei, J. et al. SNX8 mediates IFNgamma-triggered noncanonical signaling pathway and host defense against Listeria monocytogenes. Proc. Natl Acad. Sci. USA 114, 13000–13005 (2017).
Xu, L. G. et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19, 727–740 (2005).
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).
Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84–87 (2014).
We thank Wen-Rui He, Hao Huang, and Chen-Yang Liao for technical help. This work was supported by grants from the State Key R&D Program of China (2017YFA0505800, 2016YFA0502102), and the National Natural Science Foundation of China (31630045, 31521091, 91429304, and 31671465).
The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Lian, H., Wei, J., Zang, R. et al. ZCCHC3 is a co-sensor of cGAS for dsDNA recognition in innate immune response. Nat Commun 9, 3349 (2018). https://doi.org/10.1038/s41467-018-05559-w
The Hippo signaling component LATS2 enhances innate immunity to inhibit HIV-1 infection through PQBP1-cGAS pathway
Cell Death & Differentiation (2022)
Cellular & Molecular Immunology (2021)
Signal Transduction and Targeted Therapy (2021)
The RNA-binding protein LUC7L2 mediates MITA/STING intron retention to negatively regulate innate antiviral response
Cell Discovery (2021)
Nature Communications (2020)